[go: up one dir, main page]

HK1229330B - 作为用於治疗癌症的raf抑制剂的1-(5-叔丁基-2-芳基-吡唑-3-基)-3-[2-氟-4-[(3-氧代-4h-吡啶并[2，3-b]吡嗪-8-基)氧基]苯基]脲衍生物 - Google Patents

作为用於治疗癌症的raf抑制剂的1-(5-叔丁基-2-芳基-吡唑-3-基)-3-[2-氟-4-[(3-氧代-4h-吡啶并[2，3-b]吡嗪-8-基)氧基]苯基]脲衍生物 Download PDF

Info

Publication number
HK1229330B
HK1229330B HK17103128.0A HK17103128A HK1229330B HK 1229330 B HK1229330 B HK 1229330B HK 17103128 A HK17103128 A HK 17103128A HK 1229330 B HK1229330 B HK 1229330B
Authority
HK
Hong Kong
Prior art keywords
compound
treatment
cancer
braf
cell
Prior art date
Application number
HK17103128.0A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1229330A1 (zh
Inventor
卡洛琳‧乔伊‧斯普林格
理查德‧马莱斯
罗米娜‧吉罗蒂
丹‧尼库列斯库-杜瓦斯
伊昂‧尼库列斯库-杜瓦斯
阿方索‧赞姆邦
Original Assignee
癌症研究科技有限公司
癌症研究协会:皇家癌症医院
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 癌症研究科技有限公司, 癌症研究协会:皇家癌症医院 filed Critical 癌症研究科技有限公司
Publication of HK1229330A1 publication Critical patent/HK1229330A1/zh
Publication of HK1229330B publication Critical patent/HK1229330B/zh

Links

HK17103128.0A 2013-11-25 2014-11-25 作为用於治疗癌症的raf抑制剂的1-(5-叔丁基-2-芳基-吡唑-3-基)-3-[2-氟-4-[(3-氧代-4h-吡啶并[2，3-b]吡嗪-8-基)氧基]苯基]脲衍生物 HK1229330B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1320729.5 2013-11-25

Publications (2)

Publication Number Publication Date
HK1229330A1 HK1229330A1 (zh) 2017-11-17
HK1229330B true HK1229330B (zh) 2020-04-29

Family

ID=

Similar Documents

Publication Publication Date Title
US10167282B2 (en) 1-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido [2, 3-B]pyrazin- 8-yl)oxy]phenyl]urea derivatives as RAF inhibitors for the treatment of cancer
JP2024543983A (ja) がんの処置のための縮環２－アミノ－３－シアノチオフェン及び誘導体
KR20120102669A (ko) 키나제 조정을 위한 화합물 및 방법, 및 이를 위한 적응증
US11446301B2 (en) Quinoline analogs as phosphatidylinositol 3-kinase inhibitors
KR20090129434A (ko) 피리미딘-2,4-디아민 유도체 및 ｊａｋ2 키나제 억제제로서의 이의 용도
TWI667236B (zh) 作為蛋白激酶抑制劑的胺基噻唑化合物
TWI565698B (zh) 喹啉化合物，其製造方法及用途
HK1229330A1 (zh) 作为用於治疗癌症的raf抑制剂的1-(5-叔丁基-2-芳基-吡唑-3-基)-3-[2-氟-4-[(3-氧代-4h-吡啶并[2，3-b]吡嗪-8-基)氧基]苯基]脲衍生物
HK1229330B (zh) 作为用於治疗癌症的raf抑制剂的1-(5-叔丁基-2-芳基-吡唑-3-基)-3-[2-氟-4-[(3-氧代-4h-吡啶并[2，3-b]吡嗪-8-基)氧基]苯基]脲衍生物
WO2022197913A1 (en) Bicyclic derivatives which can be used to treat cancer
TWI624461B (zh) 喹唑啉化合物，其製備方法及用途